Key result
GPCS by CMR-FT predicts ~38% higher risk of malignant ventricular arrhythmias in NIDCM.
Why the study?
Identifying patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias is challenging in clinical practice.
Does cardiac magnetic resonance feature tracking (CMR-FT) identify patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias?
Cohort (n=263)
Blinded assessors
No
Does cardiac magnetic resonance feature tracking (CMR-FT) identify patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias?
Effect estimate: OR 1.38 (95% CI 1.14-1.67)
p-value: p=0.001
CMR-derived global peak circumferential strain and percent late gadolinium enhancement are independent predictors of malignant ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy.
GPCS may aid arrhythmia risk stratification in NIDCM; leaves open need for prospective validation before clinical use.
BACKGROUND: Patients with nonischemic dilated cardiomyopathy (NIDCM) are prone to arrhythmias, and the cause of mortality in these patients is either end-organ dysfunction due to pump failure or malignant arrhythmia-related death. However, the identification of patients with NIDCM at risk of malignant ventricular arrhythmias (VAs) is challenging in clinical practice. The aim of this study was to evaluate whether cardiovascular magnetic resonance feature tracking (CMR-FT) could help in the identification of patients with NIDCM at risk of malignant VAs. METHODS: A total of 263 NIDCM patients who underwent CMR, 24-hour Holter electrocardiography (ECG) and inpatient ECG were retrospectively evaluated. The patients with NIDCM were allocated to two subgroups: NIDCM with VAs and NIDCM without VAs. From CMR-FT, the global peak radial strain (GPRS), global longitudinal strain (GPLS), and global peak circumferential strain (GPCS) were calculated from the left ventricle (LV) model. We investigated the possible predictors of NIDCM combined with VAs by univariate and multivariate logistic regression analyses. RESULTS: The percent LGE (15.51 ± 3.30 vs. 9.62 ± 2.18, P < 0.001) was higher in NIDCM patients with VAs than in NIDCM patients without VAs. Furthermore, the NIDCM patients complicated with VAs had significantly lower GPCS than the NIDCM patients without VAs (- 5.38 (- 7.50, - 4.22) vs.-9.22 (- 10.73, - 8.19), P < 0.01). Subgroup analysis based on LGE negativity showed that NIDCM patients complicated with VAs had significantly lower GPRS, GPCS, and GPLS than NIDCM patients without VAs (P < 0.05 for all). Multivariate analysis showed that both GPCS and %LGE were independent predictors of NIDCM combined with VAs. CONCLUSIONS: CMR global strain can be used to identify NIDCM patients complicated with VAs early, specifically when LGE is not present. GPCS < - 13.19% and %LGE > 10.37% are independent predictors of NIDCM combined with VAs.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) conducted a cohort in Nonischemic dilated cardiomyopathy (NIDCM) (n=263). Cardiovascular magnetic resonance feature tracking (CMR-FT) vs. NIDCM patients without ventricular arrhythmias was evaluated on Predictors of NIDCM combined with ventricular arrhythmias (Global peak circumferential strain) (OR 1.38, 95% CI 1.14-1.67, p=0.001). Global peak circumferential strain (GPCS) assessed by CMR-FT was an independent predictor of malignant ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy (OR 1.38).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: